Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00091572 · BASELINE

Baseline characteristics

Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267) · Source last updated 2017-06-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      429
    2. group Id
      BG001
      value
      430
    3. group Id
      BG002
      value
      859
    units
    Participants
groups
  1. description
    temozolomide 150 mg/m2/day PO, on 7 consecutive days every 14 days ("7 days on / 7 days off" continuously)
    id
    BG000
    title
    Temozolomide
  2. description
    dacarbazine 1000 mg/m2 IV, on Day 1 +/- 3 days every 3 weeks
    id
    BG001
    title
    Dacarbazine
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        <=18 years
      2. measurements
        1. group Id
          BG000
          value
          276
        2. group Id
          BG001
          value
          261
        3. group Id
          BG002
          value
          537
        title
        Between 18 and 65 years
      3. measurements
        1. group Id
          BG000
          value
          153
        2. group Id
          BG001
          value
          169
        3. group Id
          BG002
          value
          322
        title
        >=65 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Categorical
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          179
        2. group Id
          BG001
          value
          177
        3. group Id
          BG002
          value
          356
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          250
        2. group Id
          BG001
          value
          253
        3. group Id
          BG002
          value
          503
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      429
    2. group Id
      BG001
      value
      430
    3. group Id
      BG002
      value
      859
    units
    Participants
groups
  1. description
    temozolomide 150 mg/m2/day PO, on 7 consecutive days every 14 days ("7 days on / 7 days off" continuously)
    id
    BG000
    title
    Temozolomide
  2. description
    dacarbazine 1000 mg/m2 IV, on Day 1 +/- 3 days every 3 weeks
    id
    BG001
    title
    Dacarbazine
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        <=18 years
      2. measurements
        1. group Id
          BG000
          value
          276
        2. group Id
          BG001
          value
          261
        3. group Id
          BG002
          value
          537
        title
        Between 18 and 65 years
      3. measurements
        1. group Id
          BG000
          value
          153
        2. group Id
          BG001
          value
          169
        3. group Id
          BG002
          value
          322
        title
        >=65 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Categorical
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          179
        2. group Id
          BG001
          value
          177
        3. group Id
          BG002
          value
          356
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          250
        2. group Id
          BG001
          value
          253
        3. group Id
          BG002
          value
          503
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice